Early research (Phase 1)Study completedNCT00055705What this trial is testingPV701 in Treating Patients With Advanced or Recurrent Peritoneal CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00400569What this trial is testingPhase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue SarcomaWho this might be right forLiposarcomaLeiomyosarcomaFibrosarcoma+1 more H. Lee Moffitt Cancer Center and Research Institute 48
Testing effectiveness (Phase 2)Study completedNCT00112463What this trial is testingDepsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue SarcomaWho this might be right forAdult Alveolar Soft-part SarcomaAdult AngiosarcomaAdult Epithelioid Sarcoma+17 more National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07647068What this trial is testingAutologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal TumorsWho this might be right forLocally Advanced Gastrointestinal Stromal TumorMetastatic Gastrointestinal Stromal TumorRecurrent Gastrointestinal Stromal Tumor+2 more Joal Beane 59
Early research (Phase 1)Study completedNCT00005860What this trial is testingOxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the PeritoneumWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02500797What this trial is testingNivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by SurgeryWho this might be right forLocally Advanced Bone SarcomaLocally Advanced Dedifferentiated LiposarcomaLocally Advanced Gastrointestinal Stromal Tumor+18 more National Cancer Institute (NCI) 164
Not applicableLooking for participantsNCT05461664What this trial is testingAvapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRAWho this might be right forGastrointestinal Stromal TumorsUnresectable Solid TumorRecurrent Metastatic Malignant Neoplasm Xinhua Zhang, MD 74
Testing effectiveness (Phase 2)Study completedNCT00237185What this trial is testingThe Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit GeneWho this might be right forUnresectable or Metastatic Malignant Gastrointestinal Stromal Tumor (GIST) Novartis Pharmaceuticals 148
Large-scale testing (Phase 3)Study completedNCT00293124What this trial is testingOpen-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal TumorsWho this might be right forGastrointestinal Stromal Tumors Central European Cooperative Oncology Group 125
Not applicableLooking for participantsNCT05464875What this trial is testingStudy of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal TumorsWho this might be right forGastrointestinal Stromal TumorsUnresectable Solid TumorRecurrent Metastatic Malignant Neoplasm Xinhua Zhang, MD 74
Testing effectiveness (Phase 2)Study completedNCT01294202What this trial is testingInvestigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GISTWho this might be right forGastrointestinal Stromal Tumor (GIST) Astex Pharmaceuticals, Inc. 26
Testing effectiveness (Phase 2)UnknownNCT03171389What this trial is testingPOETIG Trial - POnatinib After rEsisTance to Imatinib in GISTWho this might be right forGIST, MalignantKIT Exon 13 MutationKIT Gene Mutation Sebastian Bauer 81